Should I buy Axon Enterprise (AXON) stock or is it too late?
⭐ The most reliable of them, either direction: UBS — 65% of its targets hit on this sector (477 calls tested). It aims for $600 (-1.8 %), call made on August 7, 2026, maturing on August 7, 2027 (21 d ago).
Firm-by-firm track record on Axon Enterprise
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Barclays | 90 % | +67.5 % | 10 | $688 +13% |
| JMP Securities | 85 % | +65.2 % | 13 | $825 +35% |
| Needham | 69 % | +50.7 % | 26 | $750 +23% |
| JP Morgan | 86 % | +49.0 % | 7 | $755 +24% |
| Morgan Stanley | 50 % | +28.0 % | 8 | $640 +5% |
| Northland Capital Markets | 40 % | +22.7 % | 5 | $800 +31% |
| Raymond James | 38 % | +0.2 % | 8 | $855 +40% |
| Credit Suisse | 100 % | +54.7 % | 7 | — |
✅ Reasons to believe
- 89% of analysts rate it a buy (Buy consensus, 9 ratings) — a sign of market conviction.
- Median price target $700, i.e. +15% from the current price ($611).
- The most reliable firm on AXON, Barclays (90% hit rate, 10 scored calls), targets $688 (call made on August 6, 2026, maturing on August 6, 2027) (+13%) in its most recent call, and $702 (call made on November 6, 2025, maturing on November 6, 2026) (+15%) in the one coming due soonest.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 9 ratings, 1 is neutral.
- High valuation (P/E ~250): strong growth is already "priced in", leaving little room for error.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- No dividend: your return depends only on price appreciation.
The analyst consensus on AXON
Median target $700 (+15%) · 9 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Axon Enterprise now?
We won't decide for you. The facts: 89% of analysts rate it a buy, median target $700 (+15%), and Barclays (most reliable on AXON, 90%) targets $688. Weigh that against valuation (P/E ~250). This is not personalized advice.
Is it too late to invest in Axon Enterprise?
Not according to analysts: the median target ($700) is still +15% above the current price ($611) (most reliable on AXON: Barclays, 90%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Axon Enterprise still worth investing in?
It depends on the gap between the price ($611) and its estimated value: analysts target $700 on median (+15%), with 89% buys (most reliable on AXON: Barclays, 90%). Cross-check with their real reliability on AXON and the cautions above. Information, not advice.
What's the main risk in buying AXON?
The consensus is not unanimous: of 9 ratings, 1 is neutral.
→ Go deeper: the full Axon Enterprise profile (consensus, analyst reliability, price target, performance).